Controlling Drug Safety: Making Cautious Changes

  • R. D. Mann
Conference paper
Part of the Health Systems Research book series (HEALTH)


What principles or broad policy issues should be occupying our attention as we consider the subject of drug safety some 29 years after the thalidomide disaster of the early 1960s? In the United Kingdom, the Medicines Act of 1964 was a direct outcome of the thalidomide disaster and this Act introduced an integrated drug regulatory process in which the safety, efficacy and quality of a medicine are considered together as a comprehensive scientific whole. So we do not have a long experience in the modern process of drug registration and regulation, and we should accept the need for humility in discussing principles to lead us into the future. We need to be careful in changing the processes and procedures that we use in controlling drug safety, but changes will necessary.


Informed Choice Modern Process Iatrogenic Event Referee Journal Legal Nature 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mann RD, Havard J (1989) No fault compensation in medicine. Royal Society of Medicine Services, LondonGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • R. D. Mann

There are no affiliations available

Personalised recommendations